Loss of heterozygosity atBRCA1/2 loci in hereditary and sporadic ovarian cancers |
| |
Authors: | I Bro?ek K Ochman J D?bniak L Morzuch M Ratajska M Stepnowska M Stukan J Emerich J Limon |
| |
Institution: | 1. Department of Biology and Genetics, Medical University of Gdańsk, D?binki 1, 80-211, Gdańsk, Poland 2. Regional Oncological Center of Gdańsk, Poland 3. Department of Gynecology, Medical University of Gdańsk, Poland
|
| |
Abstract: | Loss of heterozygosity atBRCA1/2 loci in breast and ovarian tumors is a suggested risk factor for germlineBRCA1/2 mutation status. We evaluated the presence of losses of selected microsatellite markers localized on chromosomes 17 and 13q
in hereditary and sporadic ovarian tumors. 151 consecutive primary ovarian tumors (including 21 withBRCA1/2 mutations and 130 without the mutations) were screened for loss of heterozygosity at loci on chromosomes 17 and 13q. Losses
of heterozygosity of at least one microsatellite marker localized on chromosomes 17 and 13q were revealed in 123 (81.5%) and
104 (68.9%) tumors, respectively. Losses of all informative markers on chromosomes 17 and 13 occurred in 30 (19.9%) and 31
(20.5%) tumors, respectively. There was no difference in the frequency of losses atBRCA1 intragenic markers (D17S855 and D17S1323) between BRCA1-positive and BRCA1-negative patients. The frequency of losses on
chromosome 17 was higher in high-grade than in low-grade carcinomas. Loss of heterozygosity on chromosomes 17 and 13q is a
frequent phenomenon in both hereditary and sporadic ovarian cancers. The frequency of losses atBRCA1 intragenic markers in the ovarian tumor tissue is not strongly related to the presence ofBRCA1 germline mutations. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|